Journal of Ophthalmology

Microinvasive Glaucoma Surgery


Status
Published

Lead Editor

1National University Hospital, Singapore

2Moorfields Eye Hospital, London, UK

3Montreal Glaucoma Institute, Montreal, Canada


Microinvasive Glaucoma Surgery

Description

Microinvasive glaucoma surgery (MIGS) refers to a new group of surgical procedures which are characterized by the following features: high safety profile, minimal trauma, at least moderate efficacy, ease of use and rapid recovery. The implantation of MIGS devices has increased significantly in the last few years, with several devices obtaining the Conformité Européene mark (iStent trabecular microbypass stent, XEN-45 implant, Hydrus and Cypass) and the United States Food and Drug Administration approval (iStent trabecular microbypass stent) approval. The high safety profile of MIGS allows it to be used earlier than conventional glaucoma surgeries within the glaucoma treatment algorithm, and it is typically combined with cataract surgery in patients with mild-to-moderate primary open angle glaucoma. Other indications for MIGS, the efficacy of MIGS as a solo procedure, and prognostic factors for success after MIGS implantation remain to be determined.

We invite investigators to contribute original research papers which will enhance our understanding of MIGS, its surgical outcomes, and how it compares with other glaucoma treatment modalities.

Potential topics include but are not limited to the following:

  • Efficacy of MIGS devices implanted as solo procedures
  • Comparative studies between MIGS devices and other treatment options for glaucoma, for example, glaucoma medications, cataract surgery alone, and trabeculectomy
  • Pilot studies relevant to the implantation of MIGS devices for indications other than mild-to-moderate primary open angle glaucoma
  • Studies investigating prognostic factors for success after MIGS
  • Imaging of MIGS devices after implantation and correlation with surgical outcomes
  • Complications associated with MIGS devices and management strategies
  • Laboratory-based microfluidic or histological studies involving MIGS devices
  • Health services and systems research on MIGS devices, including studies on cost-effectiveness and quality of life

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 9845018
  • - Editorial

Microinvasive Glaucoma Surgery

Chelvin C. A. Sng | Paul Harasymowycz | Keith Barton
  • Special Issue
  • - Volume 2017
  • - Article ID 7136275
  • - Review Article

High-Intensity Focused Ultrasound Circular Cyclocoagulation in Glaucoma: A Step Forward for Cyclodestruction?

Rodolfo Mastropasqua | Vincenzo Fasanella | ... | Luca Agnifili
  • Special Issue
  • - Volume 2017
  • - Article ID 3182935
  • - Review Article

Safety and Efficacy of Microinvasive Glaucoma Surgery

David Z. Chen | Chelvin C. A. Sng
  • Special Issue
  • - Volume 2017
  • - Article ID 8248710
  • - Clinical Study

Short-Term Clinical Results of Ab Interno Trabeculotomy Using the Trabectome with or without Cataract Surgery for Open-Angle Glaucoma Patients of High Intraocular Pressure

Handan Akil | Vikas Chopra | ... | Brian A. Francis
  • Special Issue
  • - Volume 2017
  • - Article ID 5457246
  • - Clinical Study

XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications

Ahmed Galal | Alper Bilgic | ... | Amr Osman
  • Special Issue
  • - Volume 2017
  • - Article ID 9605461
  • - Clinical Study

Safety and Efficacy of Two Trabecular Micro-Bypass Stents as the Sole Procedure in Japanese Patients with Medically Uncontrolled Primary Open-Angle Glaucoma: A Pilot Case Series

Daisuke Shiba | Shingo Hosoda | ... | Kazuo Tsubota
  • Special Issue
  • - Volume 2016
  • - Article ID 1056573
  • - Clinical Study

Glaukos iStent inject® Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients with Coexisting Cataract and Open-Angle Glaucoma or Ocular Hypertension: A Long-Term Study

Pedro Arriola-Villalobos | Jose Maria Martinez-de-la-Casa | ... | Julian Garcia-Feijoo
Journal of Ophthalmology
 Journal metrics
Acceptance rate36%
Submission to final decision74 days
Acceptance to publication31 days
CiteScore2.800
Impact Factor1.447
 Submit